Gregory S. Moss
Insider Reports History
- Location
- New York, NY
- Signature
- /s/ Gregory S. Moss
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Gregory S. Moss:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Evommune, Inc. | Chief Business & Legal Officer | Common Stock | 60,835 | $1,085,296 | $17.84 | 09 Dec 2025 | Direct |
| Evommune, Inc. | Chief Business & Legal Officer | Common Stock | 3,175 | $61,817 | $19.47 | 09 Dec 2025 | By Trust |
| Evommune, Inc. | Chief Business & Legal Officer | Employee Stock Option (Right to Buy) | 115,279 | 16 Apr 2026 | Direct | ||
| Anteris Technologies Global Corp. | Director | Restricted Stock Units | 13,821 | 03 Dec 2025 | Direct | ||
| Evommune, Inc. | Chief Business & Legal Officer | Series B Preferred Stock | 0 | 07 Nov 2025 | By Trust | ||
| Kadmon Holdings, Inc. | EVP, Gen. Coun. / CCO. | Common Stock | 0 | $9.50 | 09 Nov 2021 | Direct | |
| Kadmon Holdings, Inc. | EVP, Gen. Coun. / CCO. | Equity Appreciation Rights Unit | 0 | $3.50 | 09 Nov 2021 | Direct | |
| Kadmon Holdings, Inc. | EVP, Gen. Coun. / CCO. | Performance Stock Option (right to buy) | 0 | $5.44 | 09 Nov 2021 | Direct | |
| Kadmon Holdings, Inc. | EVP, Gen. Coun. / CCO. | Stock Appreciation Right | 0 | $5.86 | 09 Nov 2021 | Direct | |
| Kadmon Holdings, Inc. | EVP, Gen. Coun. / CCO. | Stock Option (right to buy) | 0 | $5.54 | 09 Nov 2021 | Direct |